JANET BUTEL to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications JANET BUTEL has written about Reverse Transcriptase Inhibitors.
Connection Strength
0.049
-
The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era. Medicine (Baltimore). 2003 Mar; 82(2):77-81.
Score: 0.049
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.